Xponance, Inc. Sarepta Therapeutics, Inc. Transaction History

Xponance, Inc.

$12.3 Billion
Q3 2025

A detailed history of Xponance, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 11,945 shares of SRPT stock, worth $224,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,945

Previous 17,895 33.25%

Holding current value

$224,685

Previous $306,000 24.84%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$11.93 - $21.97 $70,983 - $130,721	-5,950 Reduced 33.25%	11,945 $230,000
Q2 2025 Aug 14, 2025	SELL	$17.1 - $63.66 $24,384 - $90,779	-1,426 Reduced 7.38%	17,895 $306,000
Q1 2025 Apr 30, 2025	BUY	$63.82 - $127.89 $38,802 - $77,757	608 Added 3.25%	19,321 $1.23 Million
Q4 2024 Feb 10, 2025	BUY	$104.54 - $137.94 $59,692 - $78,763	571 Added 3.15%	18,713 $2.28 Million
Q3 2024 Nov 12, 2024	SELL	$124.33 - $156.75 $50,229 - $63,327	-404 Reduced 2.18%	18,142 $2.27 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $805,322 - $1.16 Million	7,106 Added 62.12%	18,546 $2.93 Million
Q1 2024 May 13, 2024	SELL	$93.7 - $141.53 $26,985 - $40,760	-288 Reduced 2.46%	11,440 $1.48 Million
Q4 2023 Jan 31, 2024	SELL	$67.31 - $124.76 $59,367 - $110,038	-882 Reduced 6.99%	11,728 $1.13 Million
Q3 2023 Oct 23, 2023	BUY	$102.5 - $123.59 $7,380 - $8,898	72 Added 0.57%	12,610 $1.53 Million
Q2 2023 Jul 13, 2023	BUY	$106.4 - $157.19 $111,826 - $165,206	1,051 Added 9.15%	12,538 $1.44 Million
Q1 2023 Apr 17, 2023	BUY	$117.53 - $155.99 $10,930 - $14,507	93 Added 0.82%	11,487 $1.58 Million
Q4 2022 Jan 23, 2023	BUY	$100.86 - $132.13 $148,970 - $195,156	1,477 Added 14.89%	11,394 $0
Q3 2022 Oct 24, 2022	BUY	$75.71 - $119.24 $4,088 - $6,438	54 Added 0.55%	9,917 $1.1 Million
Q2 2022 Aug 02, 2022	BUY	$62.69 - $88.44 $30,028 - $42,362	479 Added 5.1%	9,863 $739,000
Q1 2022 Apr 20, 2022	BUY	$63.15 - $90.42 $3,283 - $4,701	52 Added 0.56%	9,384 $733,000
Q4 2021 Jan 31, 2022	BUY	$77.28 - $99.42 $59,660 - $76,752	772 Added 9.02%	9,332 $840,000
Q3 2021 Nov 05, 2021	SELL	$65.97 - $92.48 $22,759 - $31,905	-345 Reduced 3.87%	8,560 $792,000
Q2 2021 Aug 12, 2021	BUY	$69.38 - $86.75 $75,971 - $94,991	1,095 Added 14.02%	8,905 $692,000
Q1 2021 May 10, 2021	SELL	$72.25 - $168.95 $794 - $1,858	-11 Reduced 0.14%	7,810 $582,000
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $11,049 - $15,729	88 Added 1.14%	7,821 $1.33 Million
Q3 2020 Oct 26, 2020	SELL	$127.12 - $172.34 $4,957 - $6,721	-39 Reduced 0.5%	7,733 $1.09 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $722,796 - $1.33 Million	7,772 New	7,772 $1.25 Million

Others Institutions Holding SRPT

# of Institutions

421

Shares Held

85.8M

Call Options Held

5.66M

Put Options Held

6.11M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account